UDPG/P2Y14-STAT1 axis mediates LPS-induced reactive astrogliosis

Astrocytes play a vital role in neuroinflammatory processes within the central nervous system (CNS). Increasing evidence suggests that purinergic G protein-coupled receptor P2Y<sub>14</sub> is associated with neuroinflammation. However, the expression, distribution, and function of P2Y<sub>14</sub> in astrocytes remain unclear. This study aimed to investigate the expression of P2Y<sub>14</sub> receptors in astrocytes and their regulatory role in astrocytic inflammatory responses. P2Y<sub>14</sub> expression was confirmed in primary astrocytes isolated from the mouse cerebral cortex using immunofluorescence techniques. Western blot and RT-qPCR analyses showed that lipopolysaccharide (LPS) stimulation significantly increased P2Y<sub>14</sub> expression in astrocytes. The antagonist of P2Y<sub>14</sub> receptor, 4-(piperidin-4-yl)-phenyl)-7-(4-(trifluoromethyl)-phenyl2-naphthoic acid (PPTN) reduced glial fibrillary acidic protein (GFAP) expression, while the agonist of P2Y<sub>14</sub> receptor, uridine diphosphate glucose (UDPG) promoted it in astrocytes. Mechanistically, PPTN inhibited the expression of signal transducer and activator of transcription 1 (STAT1) and its phosphorylated form (p-STAT1), while UDPG enhanced the activation of STAT1/p-STAT1. Treatment with the P2Y<sub>14</sub> antagonist PPTN resulted in significant inhibition of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-α) release. By contrast, stimulation of the P2Y<sub>14</sub> receptor with its agonist UDPG induced a substantial increase in the levels of these inflammatory mediators. These results were further validated in the cell line of mouse astrocyte C8-D1A using pharmacological approaches and lentiviral transduction to modulate P2Y<sub>14</sub> expression. This study confirmed that astrocytes express functional P2Y<sub>14</sub> receptors and demonstrated their key role in regulating astrocyte activation and inflammatory responses. This regulation may be achieved through the UDPG/P2Y<sub>14</sub>-STAT1 signaling axis, which provides a new molecular basis for understanding the regulatory mechanisms of astrocytic inflammatory responses.

Authors

Institutions

Publication Details

Journal
Neuropharmacology
Published
2025-10-14
DOI
https://doi.org/10.1016/j.neuropharm.2025.110723
Primary Topic
Adenosine and Purinergic Signaling
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

UDPG/P2Y14-STAT1 axis mediates LPS-induced reactive astrogliosis

Yong Tang, Péter Illés, Patrizia Rubini, Peng Yang et al.
Neuropharmacology
Adenosine and Purinergic Signaling
article

UDPG/P2Y14-STAT1 axis mediates LPS-induced reactive astrogliosis

Yong Tang, Péter Illés, Patrizia Rubini, Peng Yang, Yuan-Hong Deng, Xiao Ran, Si‐Si Lin, Wenjing Ren, Mengyao Wang
article en

Abstract

Astrocytes play a vital role in neuroinflammatory processes within the central nervous system (CNS). Increasing evidence suggests that purinergic G protein-coupled receptor P2Y<sub>14</sub> is associated with neuroinflammation. However, the expression, distribution, and function of P2Y<sub>14</sub> in astrocytes remain unclear. This study aimed to investigate the expression of P2Y<sub>14</sub> receptors in astrocytes and their regulatory role in astrocytic inflammatory responses. P2Y<sub>14</sub> expression was confirmed in primary astrocytes isolated from the mouse cerebral cortex using immunofluorescence techniques. Western blot and RT-qPCR analyses showed that lipopolysaccharide (LPS) stimulation significantly increased P2Y<sub>14</sub> expression in astrocytes. The antagonist of P2Y<sub>14</sub> receptor, 4-(piperidin-4-yl)-phenyl)-7-(4-(trifluoromethyl)-phenyl2-naphthoic acid (PPTN) reduced glial fibrillary acidic protein (GFAP) expression, while the agonist of P2Y<sub>14</sub> receptor, uridine diphosphate glucose (UDPG) promoted it in astrocytes. Mechanistically, PPTN inhibited the expression of signal transducer and activator of transcription 1 (STAT1) and its phosphorylated form (p-STAT1), while UDPG enhanced the activation of STAT1/p-STAT1. Treatment with the P2Y<sub>14</sub> antagonist PPTN resulted in significant inhibition of interleukin (IL)-6, IL-18, and tumor necrosis factor-alpha (TNF-α) release. By contrast, stimulation of the P2Y<sub>14</sub> receptor with its agonist UDPG induced a substantial increase in the levels of these inflammatory mediators. These results were further validated in the cell line of mouse astrocyte C8-D1A using pharmacological approaches and lentiviral transduction to modulate P2Y<sub>14</sub> expression. This study confirmed that astrocytes express functional P2Y<sub>14</sub> receptors and demonstrated their key role in regulating astrocyte activation and inflammatory responses. This regulation may be achieved through the UDPG/P2Y<sub>14</sub>-STAT1 signaling axis, which provides a new molecular basis for understanding the regulatory mechanisms of astrocytic inflammatory responses.

NeuropharmacologyVol. 283
Chengdu University of Traditional Chinese Medicine (CN), Leipzig University (DE)
Openalex Percentile: Top 71%
Adenosine and Purinergic Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.